VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms
- 1 May 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (5) , 608-623
- https://doi.org/10.1038/labinvest.3700258
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular Endothelial Growth Factor: Acting as an Autocrine Growth Factor for Human Gastric Adenocarcinoma Cell MGC803Biochemical and Biophysical Research Communications, 2001
- Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogeneOncogene, 1999
- OncogenicrasFails to Restore anin VivoTumorigenic Phenotype in Embryonic Stem Cells Lacking Vascular Endothelial Growth Factor (VEGF)Biochemical and Biophysical Research Communications, 1999
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971